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ABSTRACT  1 
Background: In the United Kingdom pharmaceutical services can be delivered by both community 2 
pharmacies (CPs) and dispensing doctor practices (DPs). Both must adhere to minimum standards 3 
set out in NHS regulations however no common framework exists to guide quality improvement. 4 
Previous phases of this research had developed a set of characteristics indicative of good 5 
pharmaceutical service provision.  6 
Objective: To ask key stakeholders to confirm, and rank the importance of, a set of characteristics of 7 
good pharmaceutical service provision.  8 
Methods: A two-round Delphi-type survey was conducted in South-West England and was sent to 9 
participants representing three stakeholder groups: DPs, CPs and patients/lay members.  10 
Participants were asked to confirm, and rank, the importance of these characteristics as 11 
representing good quality pharmaceutical services. 12 
Key Findings: Thirty people were sent the first round survey; 22 participants completed both rounds. 13 
Median ratings for the 23 characteristics showed that all were seen to represent important aspects 14 
of pharmaceutical service provision. Participants’ comments highlighted potential problems with the 15 
practicality of the characteristics. Characteristics relating to patient safety were deemed to be the 16 
most important and those relating to public health the least important.  17 
Conclusions: A set of 23 characteristics for providing good pharmaceutical services in CPs and DPs 18 
was developed and attained approval from a sample of stakeholders. With further testing and wider 19 
discussion it is hoped that the characteristics will form the basis of a quality improvement tool for 20 
CPs and DPs.  21 
Keywords 22 
Community pharmacy; dispensing doctor; health services quality; pharmacy services; quality 23 
improvement  24 
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INTRODUCTION 25 
In the UK, primary care pharmaceutical services can be provided by both community pharmacies 26 
(CPs) and dispensing doctor practices (DPs). DPs are general medical practices that are able to 27 
provide pharmaceutical services to patients who live in an area ‘rural in character … more than one 28 
mile (1.6km) from a pharmacy’s premises’ [1]. Both CPs and DPs have to meet minimum standards 29 
of service provision set out in the National Health Services Pharmaceutical Services Regulations [2]. 30 
However, separate reimbursement schemes and monitoring procedures exist for each provider. In 31 
England, the NHS uses the Community Pharmacy Assurance Framework (CPAF) [3] to assess CPs’ 32 
compliance with the community pharmacy contractual framework. Most DPs opt to participate in 33 
the separate Dispensary Services Quality Scheme (DSQS) [4].  34 
The CPAF and DSQS focus on ensuring CPs and DPs comply with a baseline level of quality. However, 35 
the areas of service provision that focus on quality improvement (beyond a minimum baseline) are 36 
not tightly regulated and are thus open to interpretation by individual providers. With the exception 37 
of the focus group study of Halsall et al. [5] exploring quality in community pharmacy, there has 38 
been very little work investigating ideal practice or the characteristics of good pharmaceutical 39 
quality provision. This could both help guide service providers in striving to improve quality and be 40 
used to inform a series of indicators suitable for judging the quality of pharmaceutical service 41 
provision beyond a minimum baseline. In addition, a common set of characteristics for CPs and DPs 42 
would help to ensure equity of service provision to patients, regardless of where they receive 43 
pharmaceutical services. 44 
The aim of this research was to develop a set of characteristics of good pharmaceutical services, 45 
(focusing on service provision beyond the baseline level required by all providers), that could be 46 
further refined into a quality improvement tool for use in both CPs and DPs. The research was 47 
conducted in three phases, using a mixed-methods approach. The first two phases (surveys and case 48 
studies of CPs and DPs) highlighted the overall similarity between CPs and DPs with regards to 49 
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pharmaceutical service provision [6], finding as much variation within groups (CP and DP) as 50 
between. The first two phases led to the identification of a set of good service characteristics. The 51 
third phase, reported here, involved a Delphi-type, two-round survey with key stakeholders, asking 52 
them to confirm and rank the importance of these characteristics.  53 
METHOD 54 
Ethical approval for all three phases of the research was granted by the Southmead NHS Ethics 55 
Committee on 31/08/11 (ref 11/SW/0203).  Phase 1 used a postal questionnaire to CPs and DPs to 56 
identify the services provided, areas of commonality and difference between CPs and DPs in service 57 
provision and any monitoring systems in place to record services. These findings informed Phase 2 of 58 
the research in which in-depth case studies of three CPs and four DPs took place. These were 59 
thematically analysed [7] to investigate how the different procedures, systems and staff dynamics at 60 
each site affected service provision over time. Through comparison and collation of data, the main 61 
overall themes that related to quality of service provision were identified. These findings have been 62 
published elsewhere [6].  63 
From these Phase 1 and 2 findings, the research team drew up an initial set of 22 characteristics of 64 
good quality pharmaceutical service. The characteristics related to four broad categories: patient 65 
safety and dispensing; patient-provider interaction; workplace culture; and public health. A two-66 
round Delphi-type survey using the approach described by Hasson et al [8] was then conducted over 67 
5 weeks in 2013, asking key stakeholders to confirm and rank the importance of the characteristics 68 
identified. Participants for the Delphi-type survey were selected purposively to represent the views 69 
of community pharmacists, dispensing GPs, dispensing staff at CPs and DPs, board members of CP 70 
and DP professional organisations and lay persons. Invitations were also sent to relevant 71 
professional organisations and two large, chain pharmacy companies.  72 
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Delphi participants could complete the surveys online or be posted paper copies. To protect 73 
anonymity, participant group (pharmacist, GP, lay) was recorded but all other identifying 74 
information was removed.  In the first round of the survey, participants were presented with the 75 
characteristics along with a brief description of what good engagement with each would look like in 76 
practice (Figure 1). Participants were asked to rate, on a scale of one to nine, the extent to which 77 
they agreed each characteristic represented an important aspect of providing a good quality 78 
pharmaceutical service (1 = completely disagree, 9 = completely agree). Participants were also 79 
invited to comment on characteristics or suggest improvements. 80 
In the second round, participants were provided with the median scores for each characteristic from 81 
round one. They were asked to rate the extent to which they agreed each characteristic represented 82 
an important aspect of good quality pharmaceutical service provision. Participants were asked to 83 
rank the characteristics within each of the four main categories in order of importance. Finally, they 84 
were asked to place those four categories in order of importance for pharmaceutical service quality. 85 
Data were entered in PASW Statistics-18 software for analysis. Free text comments were subject to 86 
content analysis: a list of categories derived from the data and research questions was drawn up and 87 
data were systematically coded into these categories [9].  88 
RESULTS 89 
Thirty-five people were directly contacted by the research team and invited to participate in the 90 
Delphi. Several individuals also circulated the invitation within their organisations to colleagues, 91 
making it impossible to calculate a response rate. Table 1 details how many people from each 92 
stakeholder group were directly contacted by the research team. 93 
Thirty people expressed a willingness to participate in the Delphi. Twenty-three participants 94 
completed the first round and were sent the second round survey, of these one failed to complete 95 
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the second survey. Table 1 displays the numbers of surveys sent and completed for each stakeholder 96 
group. 97 
Median ratings of the characteristics are given in Table 2. In general the median ratings remained 98 
the same across both rounds and all but one received a median rating of 7 or more. Several 99 
characteristics received a wide range of ratings and the ranges did not decrease in round two, 100 
indeed for some characteristics the diversity of ratings increased in the second round.  However, 101 
taking a definition of disagreement used in similar Delphi-type studies [10] of 30% or more of ratings 102 
in both the 1-3 and 7-9 tertiles, there was not sufficient disagreement among participants for any of 103 
the characteristics to be discounted.  104 
Participants were asked to place the characteristics within each category in order of importance for 105 
delivering pharmaceutical services. The mean rank assigned to each indicator was used to determine 106 
the overall order of characteristics. The characteristics are displayed in Table 2 in their final order of 107 
perceived importance, with the mean ranks given in the final column. 108 
Finally, participants ranked the four categories of characteristics in order of importance for quality of 109 
pharmaceutical services (1 = most important):  110 
1. Patient safety and dispensing (mean rank = 1.05) 111 
2. Patient-provider interaction (mean rank = 2.27) 112 
3. Workplace culture (mean rank = 3.14) 113 
4. Public health (mean rank = 3.55) 114 
Participants were not asked to rank all the characteristics across all groups (i.e. all 23 characteristics 115 
in rank order) and so, for example, the top rated characteristic in the patient-provider interaction 116 
category may not have been seen as less important than the bottom rated characteristic of the 117 
patient safety and dispensing category. 118 
Qualitative responses  119 
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Respondents were encouraged to offer comments on each of the characteristics. Although a diverse 120 
range of opinions were expressed, there were no clear differences in the types of comments 121 
expressed by the different respondent groups. That is, community pharmacists were not evidently 122 
more favourable or negative towards particular characteristics than dispensing doctors or lay 123 
respondents. 124 
Patient Safety and Dispensing 125 
All participants agreed that all staff members need to be involved in ensuring a culture of patient 126 
safety and should be encouraged to reflect on the safety of current processes. However, there was 127 
less agreement over the value of SOPs in helping to ensure safe practice, with some questioning 128 
their usability: 129 
 “They are a good set of ideals … their shortfall is the detail. The volume and individual steps 130 
are impossible to retain exactly and to practice exactly.” (Community pharmacist 2) 131 
There were also differences in opinions on how prescriptions should be checked, with some 132 
participants viewing double checking (where a dispensed prescription is checked by two members of 133 
staff) as the only correct way to practice and others feeling that, as long as systems are in place to 134 
prevent errors (such as ensuring a gap is left between assembling and conducting the final check on 135 
a prescription), single checking is acceptable. Although all participants agreed that interruptions 136 
during dispensing heightened the risk of error, a few felt that the suggestion to keep interruptions to 137 
a minimum could be misinterpreted or would be unfeasible: 138 
“Not always practical as pharmacists are unable to avoid interaction with the public. Design 139 
of modern open plan dispensaries makes this even more difficult. ” (Community pharmacy 140 
Executive 1) 141 
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All participants agreed that recording and reflecting on errors and near misses is important; 142 
unfortunately some of the participants working in CPs and DPs reported that there was a tendency 143 
to blame individuals, which prevented reporting and learning from errors.  144 
Patient-provider interaction 145 
Most participants strongly agreed with the importance of demonstrating a patient-centred ethos. 146 
Only one participant disagreed, feeling that patients needed to take more responsibility for their 147 
health. One participant disagreed with the importance of staff ensuring patients understand why 148 
and how to take their medications, believing this to be the prescriber’s role.  149 
Although a few participants felt that staff training on communication would not be feasible in 150 
smaller practices, several highlighted the importance of good staff-patient communication, not only 151 
for business purposes but also for ensuring treatment adherence and picking up on potential 152 
problems:  153 
“It is an important role that can influence patient's compliance and identify possible 154 
problems. I'm not sure this is given a high enough priority in dispensaries but it will become 155 
more essential as the population ages.” (Lay member 1) 156 
Engaging with patients to ensure good customer service was agreed to be important by all but 157 
several people disagreed with the need for a SOP on handling times when staff are unable to 158 
immediately deal with a patient: 159 
“I don't think customers mind waiting as long as they can see you are not just talking about 160 
what you had for dinner last night. You make it known you have seen them by smiling at 161 
them and saying ‘I will be with you soon’.” (CP dispensing assistant 1) 162 
“We do acknowledge patients but I do not believe there is a SOP. That might be an excessive 163 
micro-SOP. It’s just good manners really. (Community Pharmacist 8) 164 
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The service characteristic concerning medicines use reviews (MURs) and dispensing reviews of use of 165 
medicines (DRUMs) was divisive: several participants agreed that these checks should only be 166 
carried out with patients whom staff believe would benefit from a review. However, some 167 
participants pointed out that it is hard to tell the potential value of a review beforehand: 168 
“You often don’t know the full benefit till you start the consultation with the patient and 169 
appreciate their unspoken needs.” (Community pharmacist 3) 170 
However, if staff have the freedom to decide when to conduct an MUR, the fear was that they might 171 
not conduct any.  172 
A member of staff who is pressed for time may decide that there is nothing to be gained by 173 
conducting a MUR / DRUM, whereas the patient might clearly benefit from one. (Lay 174 
member 2) 175 
Workplace culture 176 
All participants agreed that having established methods of communication among staff is important 177 
for providing good quality service. Promoting an ethos where staff feel able to make suggestions for 178 
improvements and to learn about other providers’ systems was generally deemed important. 179 
Training and CPD were mostly acknowledged as important for providing “better qualified staff, more 180 
self-confidence and job satisfaction, and better patient care” (Community pharmacist 4). However, 181 
several of the participants reported that some mandatory courses had been irrelevant and they 182 
could not see how study time could be integrated into an already busy schedule.  183 
Linking up with other providers to share knowledge and experience was seen as something to aim 184 
for, but unlikely to happen due to time pressures, confidentiality regulations and, possibly, 185 
competition for business hindering attempts to work together: 186 
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“Good idea.... But for a busy GP practice with several different pharmacies surrounding it..... 187 
[I] question the practicality” (Community Pharmacy Executive 2) 188 
Public health 189 
While the majority of participants felt that it was important for all staff in a CP or DP dispensary to 190 
be able to provide up-to-date public health information, two participants felt that this was the role 191 
only of the pharmacist, practice nurse or GP. Overall, the public health characteristics were seen as 192 
less important than those in the other categories, with several participants viewing public health as 193 
‘secondary’ or ‘peripheral’ to pharmaceutical services. So, although having well-presented 194 
information of available services was seen as ideal and “a good place to give health advice” 195 
(Dispensing GP 2), this should not be “at the expense of (for example) a well-stocked pharmacy” (Lay 196 
member 2). On the other hand, there were also several comments highlighting that health 197 
promotion is an “increasingly important role” (Community pharmacist 5) for all staff in primary care. 198 
A lack of space was reported as a common barrier to providing better health promotion and public 199 
health services.  200 
DISCUSSION 201 
The study addressed areas of service provision that focus on quality improvement beyond a 202 
minimum baseline that are not tightly regulated and therefore are open to interpretation by 203 
individual providers. Of the 23 characteristics investigated, all were rated as being important aspects 204 
of pharmaceutical service provision, with characteristics relating to patient safety perceived to be 205 
the most important. This study is the first to characterise the quality of pharmaceutical service 206 
provision across both CPs and DPs.  207 
All the characteristics identified were retained as being important throughout the Delphi, and it may 208 
be that it was not possible for respondents to make distinctions between the different 209 
characteristics in terms of assessing importance. This was a relatively small study and, despite 210 
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attempts to fairly represent both DPs and CPs, only two dispensing GPs completed both rounds of 211 
the survey with no one from Dispensing Doctor Organisations participating. However, development 212 
of the characteristics was informed by previous phases of the research which had involved more 213 
DPs. While the characteristics were largely based on findings from the South West of England, six 214 
national primary care organisations were involved in the Delphi rounds. 215 
General conceptual frameworks of quality in primary care have previously been developed [11]. In 216 
community pharmacy, Halsall et al. used a Donabedian framework to analyse focus group 217 
discussions with pharmacy users and staff [5]. They identified the three interdependent dimensions 218 
of accessibility, effectiveness and positive perceptions of the experience as characterising quality in a 219 
community pharmacy setting [5]. The current study adopted a different approach to Halsall et al., to 220 
inductively triangulate a variety of qualitative and quantitative data, involving both CPs and DPs, and 221 
focusing on quality above a minimum baseline.  222 
The ambivalence towards public health practices revealed in participants’ comments seems 223 
particularly noteworthy given the United Kingdom Department of Health’s current emphasis on 224 
health promotion and shift towards preventive care [12].  There seemed to be a belief among some 225 
participants that, although public health and health promotion campaigns were important, they 226 
were not within the remit of primary care. The need for better acknowledgement by primary care 227 
practitioners of their role in public health has been reported previously [13]. While primary care 228 
professional bodies have produced resources to help practices increase their involvement in public 229 
health [14, 15], more action needs to be taken if the Department of Health’s aims are to be met.  230 
In addition to investigating the applicability of these characteristics in a wider population of CPs and 231 
DPs, further work is needed to develop and test a tool, based on the characteristics, that helps staff 232 
at CPs and DPs to identify areas where quality could be improved and then to make changes to 233 
practice. It is important to bear in mind, however, that assessing performance can lead to 234 
dysfunctional consequences [16] called ‘measurement fixation’: where staff focus solely on meeting 235 
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specific targets rather than understanding the ‘spirit’ of the characteristic. While some of the 236 
characteristics might be easily assessed using traditional measures (such as number of dispensing 237 
errors), it has been the aim of the research team, in agreement with recommendations by the King’s 238 
Fund [17], not to ignore those aspects of quality that are less easily quantifiable, such as culture, 239 
ethos and morale. Therefore innovative qualitative methods are also called for. Examples suggested 240 
include “mystery shopper”-style visits to assess specific aspects of patient-provider interaction and 241 
health promotion, random spot checks to assess staff understanding of SOPs, auditing the reasons 242 
behind un-filled prescriptions, and keeping minutes of staff meetings to review errors. It will be 243 
important to ascertain what form of quality improvement resource service providers would find 244 
most useful. For example, a reflective framework, similar to the Manchester Patient Safety 245 
Framework [18], could provide users with descriptions of what increasing quality looks like on each 246 
of the characteristics found in the present study.  247 
CONCLUSION 248 
A set of 23 characteristics defining good quality pharmaceutical service provision in DPs and CPs has 249 
been developed, covering patient safety and dispensing, patient-provider interaction, workplace 250 
culture, and public health. These findings suggest that the characteristics, devised from two earlier 251 
phases of the research, were agreed by our participants to represent important aspects of providing 252 
good quality pharmaceutical services. Given the recent policy emphasis on patient safety, it is 253 
unsurprising that patient safety was perceived to be the most important aspect of good quality 254 
pharmaceutical service provision. However, it is interesting to note that some respondents were 255 
ambivalent about the importance of public health, a view at odds with current health policy 256 
initiatives and the increasing role of the pharmacist. Further work is needed to develop a tool to 257 
guide quality improvement. This could take the form of a reflective resource for service providers 258 
that will help them identify areas where quality could be improved and ultimately help them make 259 
changes to their practice that promotes quality.    260 
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Figure 1. Example characteristic with description 311 
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 314 
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Characteristic: The Practice demonstrates effective methods of internal 
staff communication.  
Description: There are agreed methods for communicating different types 
of messages (e.g. new protocols will be listed on a noticeboard for all staff 
to sign when they have read them; issues that cannot be resolved that day 
concerning a particular prescription are to be noted in the diary for next 
staff etc.). These methods are documented in a standard operating 
procedure (SOP) and, if appropriate, the SOP is also displayed as a poster 
in the dispensary for the benefit of locum/new staff. Regular practice 
review meetings should be held with all staff present or receiving minutes. 
Staff feel that they are listened to by their colleagues. Staff are required to 
reflect on how effective the communication systems are within the team 
at least annually.  
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  324 
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Table 1. Surveys sent and received by stakeholder group. 325 
 326 
Stakeholder group Number 
Contacted 
First round 
surveys sent 
First round 
surveys 
completed 
Second round 
surveys 
completed 
Dispensing GPs or practice 
managers 
10 4 3 2 
DP dispensers - 1 0 - 
Community pharmacists 8 9 8 8 
CP dispensing assistants 1 2 2 2 
DP organisation board 
members 
4 4 0 - 
CP organisation board 
members 
- 1 1 1 
Large chain CP executives 2 2 2 2 
Lay 10 7 7 7 
Total  30 23 22 
 327 
N.B. Several of the people detailed in this table also circulated the invitation to their colleagues. In addition, 328 
invitations were sent to general enquiry contact addresses for two CP organisations. 329 
  330 
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Table 2. Median and range of ratings of importance of characteristics for each round.  331 
Characteristics are displayed in rank order of importance within categories, mean rank given in 332 
final column. [where 1=completely disagree to 9 = completely agree] 333 
Service 
area 
category 
Final 
rank 
Characteristic Round 1 Round 2 Mean 
rank Median 
rating 
Range Median 
rating 
Range 
Patient 
safety and 
dispensing 
1 There is a clear culture of safety in how 
the dispensing process is managed.  
 
9.0 7-9 9.0 8-9 1.73 
2 The Practice has clear procedures for both 
second checking of prescriptions by 
another person (double checking) and 
second checking of one’s own work (single 
checking). 
 
9.0 5-9 9.0 1-9 2.95 
3 Standard operating procedures (SOPs) 
align with actual staff practice; they are 
reviewed annually and all staff understand 
and sign up to the importance of these 
procedures. 
 
7.5 2-9 7.5 6-9 3.22 
4 Patient safety is a priority; dispensing staff 
are not interrupted while dispensing a 
prescription. 
 
8.5 6-9 8.0 3-9 3.45 
5 The practice has clear SOPs for handling 
near-misses and dispensed errors. Errors 
and near-misses are recorded, reviewed 
and regularly discussed. 
 
9.0 7-9 9.0 6-9 4.27 
6 Dispensary space is optimally designed to 
ensure efficient processing of 
prescriptions. 
 
8.0 6-9 8.0 5-9 5.36 
Patient-
provider 
interaction 
1 The practice demonstrates an ethos of 
patient-centred care, committed to “going 
the extra mile” for the patient. 
 
9.0 6-9 9.0 2-9 2.41 
2 Staff ensure that all patients (and/or 
carers) understand why they should take 
their medicines, how to take them and 
any precautionary information.*  
 
- - 9.0 5-9 3.05 
3 The Practice / Pharmacy has effective and 
customer service-oriented methods of 
communicating with patients in one-to-
one interactions.  
 
8.0 1-9 8.0 3-9 3.32 
4 Each staff member demonstrates 
excellent customer service, working as a 
8.5 6-9 9.0 5-9 3.45 
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 334 
*Characteristic added in round two 335 
team to define and implement good 
service.   
 
5 Staff are always aware of and 
acknowledge waiting patients.  
 
7.5 5-9 7 4-9 3.77 
6 Practices conduct MURs / DRUMs** in a 
way that maximises patient benefit. 
 
7.5 1-9 7 3-9 5.00 
Workplace 
culture 
1 The Practice demonstrates effective 
methods of internal staff communication.  
 
8.0 1-9 8.0 6-9 2.55 
2 There is a culture of encouraging staff to 
improve internal procedures.  
 
7.0 2-9 7.0 3-9 2.77 
3 The Practice / Pharmacy facilitates staff 
training with staff having access to, and 
knowing how to use, online resources. 
 
7.0 5-9 8.0 4-9 2.91 
4 The Practice / Pharmacy makes an effort 
to develop and maintain relationships 
with other local health care providers. 
 
7.0 5-9 8.0 4-9 3.77 
5 Staff actively engage in Continuing 
Professional Development (CPD). 
 
7.5 4-9 7.0 1-9 4.77 
6 The pharmacy ensures that locum 
pharmacists are able to uphold the good 
working relationships between the 
pharmacy and local healthcare 
providers.*** 
 
8.0 5-9 8.0 2-9 4.95 
7 Sites link up to run DP and CP staff 
discussion groups on relevant issues. 
 
6.5 1-9 6.0 1-9 6.27 
Public 
health 
1 Practice / Pharmacy staff are well 
equipped to provide essential public 
health advice. 
 
8.0 1-9 8.0 3-9 2.18 
2 There is good use of patient waiting areas 
for health promotion and advice.   
 
7.0 2-9 7.0 6-9 2.50 
3 Practices / Pharmacies proactively engage 
in health promotion.  
 
7.0 4-5 7.0 5-9 2.64 
4 The services offered by the Practice / 
Pharmacy are clearly displayed.  
 
7.0 2-9 7.0 5-9 2.68 
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** MURs = medicines use reviews, DRUMs = dispensing reviews of use of medicines; these are patient 336 
consultations, conducted at CPs and DPs respectively, aiming assess how a patient is taking their medication 337 
and if they are experiencing any problems. 338 
***This characteristic relates to CPs only. 339 
 340 
